Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

XPLOSION+™ Sirolimus Eluting Coronary Stent System
Connect with this vendor - Learn about this product

XPLOSION+™ Sirolimus Eluting Coronary Stent System

XPLOSION+™ Sirolimus Eluting Coronary Stent System XPLOSION+™ Eluting Coronary Stent system is the latest in the second generation of drug eluting stents, an ultimate combination of three outstanding elements: a clinically proven drug - Sirolimus, a modified Cobalt Chromium stent platform, and an excellent bioabsorbable drug carrier. XPLOSION+™ takes the ideal definition of Safety - Efficiency - Deliverability for Percutaneous Coronary Intervention (PCI) to a higher level, convinces with its trusted technology and largest size portfolio available provides high end performance with less metallic coverage but reliable outcomes, and offers an optimal solution for improving luminal diameter and reducing in-stent restenosis when treating coronary artery lesions.